Misuse of Drugs Amendment Act 2005

  • not the latest version

Reprint as at 1 April 2008

Misuse of Drugs Amendment Act 2005

Public Act2005 No 81
Date of assent21 June 2005

Note

Changes authorised by section 17C of the Acts and Regulations Publication Act 1989 have been made in this eprint.

A general outline of these changes is set out in the notes at the end of this eprint, together with other explanatory material about this eprint.


Contents

Functions of Expert Advisory Committee on Drugs under this Part

Scheduling restricted substances

Sale and supply restrictions

Advertising restrictions and requirements

Labelling restrictions and requirements

Packaging restrictions and requirements

Health warning requirements

Signage requirements

Quantity, dosage, form, and serving restrictions and requirements

Storage and display restrictions and requirements

Manufacturing requirement

Recall

Record-keeping requirement

Certain persons prohibited from selling or manufacturing restricted substances

Enforcement officers

Enforcement powers

Offences relating to enforcement

Regulations

Code of manufacturing practice

Relationship of this Part to other specified enactments

Reprint notes


The Parliament of New Zealand enacts as follows: